EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

HIV reservoirs in lymphomagenesis: hidden driver in the era of viral suppression?

Yaoguang Li iD, Qing Xiao, Fengting Yu, Fujie Zhang iD

Microbiology and Molecular Biology Reviews · 2025

DOI: 10.1128/mmbr.00104-25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbiology and Molecular Biology Reviews, 2025. Verfasst von Yaoguang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: HIV Infections, HIV-1, Lymphoma, Lymphoma, AIDS-Related. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: John Martin Foundation, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advancements in antiretroviral therapy, people living with HIV (PLWH) remain at high risk of lymphoma. The persistence of HIV reservoirs and their spatial association with lymphoma highlights the need to clarify their role in lymphomagenesis. HIV reservoirs, which are established early during infection and maintained through clonal expansion, epigenetic silencing, and immune evasion, may contribute to lymphomagenesis through four interconnected mechanisms: provirus integration effects, viral protein-mediated disturbances, microenvironment dysregulation, and reservoir reactivation. Current therapeutic approaches that simultaneously target HIV reservoirs and lymphoma—including allogeneic hematopoietic stem cell transplantation, chimeric antigen receptor T-cell therapy, and immune checkpoint inhibitors—show promise but face substantial challenges. There is an urgent need to develop accessible strategies that can both eradicate HIV reservoirs and mitigate lymphoma risk. Such efforts may ultimately enable a “double cure” for PLWH with lymphoma, offering new hope against this life-threatening comorbidity. This review summarizes the potential links between HIV reservoirs and HIV-associated lymphoma and outlines emerging therapeutic avenues toward achieving a double cure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV-1LymphomaLymphoma, AIDS-RelatedHumansVirus LatencyDisease ReservoirsProviruses

Stichwörter der Autor:innen

CAR-T therapyHIV proteinHIV reservoirHIV-associated lymphomaHIV/AIDSallo-HSCTimmune checkpoint inhibitor

Autor:innen und Institutionen

  • Department of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Clinical Center for HIV/AIDS, Capital Medical University, Beijing, China.
  • Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.

ORCID-Profile: Yaoguang Li, Fujie Zhang

Förderung

  • John Martin Foundation
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Li, Y., Xiao, Q., Yu, F., & Zhang, F. (2025). HIV reservoirs in lymphomagenesis: hidden driver in the era of viral suppression?. Microbiology and Molecular Biology Reviews. https://doi.org/10.1128/mmbr.00104-25

Vancouver

Li Y, Xiao Q, Yu F, Zhang F. HIV reservoirs in lymphomagenesis: hidden driver in the era of viral suppression?. Microbiology and Molecular Biology Reviews. 2025. doi:10.1128/mmbr.00104-25

BibTeX
@article{Li2025,
  author = {Li, Yaoguang and Xiao, Qing and Yu, Fengting and Zhang, Fujie},
  title = {HIV reservoirs in lymphomagenesis: hidden driver in the era of viral suppression?},
  journal = {Microbiology and Molecular Biology Reviews},
  year = {2025},
  doi = {10.1128/mmbr.00104-25}
}
Kostenlos starten →